-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
It is important that multiple sclerosis (MS) is diagnosed and treated as early as possible to slow the progression of the disease
Multiple sclerosis is a disease of the central nervous system characterized by changes (lesions) in the brain
Using this technique, a research team led by Eva Niess (former Heckova) and Wolfgang Bogner from the Department of Biomedical Imaging and Image-Guided Therapy at the Vienna Medical School, in collaboration with scientists from the Vienna Medical School's Department of Neurology, have improved the results in their recently published study.
Using 7 Tesla magnetic resonance imaging, MedUni Vienna researchers have now been able to identify ms-related neurochemicals, chemicals involved in the functioning of the nervous system
More research is needed before these findings can be incorporated into clinical applications, Niess and Bogner explained
Looking to the future, Wolfgang Bergner said: "If the results are confirmed in further studies, this new neuroimaging technique could become a standard imaging tool for initial diagnosis, monitoring disease activity and treating patients with multiple sclerosis